AuntMinnie.com staff writersNuclear MedicineSNMMI and IAC collaborate on accreditation programThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Intersocietal Accreditation Commission (IAC) will launch a radiopharmaceutical therapy program.June 25, 2023Nuclear MedicineVanBrocklin receives SNMMI's Aebersold AwardHenry VanBrocklin, PhD, received the Society of Nuclear Medicine and Moleular Imaging (SNMMI) Paul C. Aebersold Award, on June 25 during the society's annual meeting in Chicago.June 25, 2023Image ProcessingImageBiopsy Lab gets FDA clearance for Lab LamaImageBiopsy Lab has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IB Lab Lama automated image processing software.June 24, 2023BreastFDA approves Bayer Ultravist injection for CEMBayer is highlighting the approval of its Ultravist injection for contrast-enhanced mammography (CEM) by the U.S. Food and Drug Administration (FDA).June 24, 2023Nuclear MedicineActinium highlights six abstracts at SNMMI 2023Radiopharmaceutical developer Actinium Pharmaceuticals is highlighting six research abstracts accepted for presentation at this week's Society for Nuclear Medicine & Molecular Imaging (SNMMI) 2023 annual meeting in Chicago.June 22, 2023PACS/VNAABII unveils new imaging informatics awardThe American Board of Imaging Informatics (ABII) is unveiling the Excellence in Imaging Informatics Award.June 22, 2023Nuclear MedicineCardinal Health to feature tech, therapy dogs at SNMMI boothCardinal Health Nuclear & Precision Health Solutions plans to showcase its Nuctrac theranostic module at the upcoming Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2023 annual meeting in Chicago.June 21, 2023Radiation Oncology/TherapyShine to open new U.S. production facilityShine Technologies is opening a facility in the U.S. that will focus on the production of lutetium-177, a medical isotope used in targeted cancer therapies.June 21, 2023Molecular ImagingRLS, Sofie enter partnership for radiopharmaceutical distributionRadioisotope Life Sciences (RLS) and Sofie Biosciences are entering into a strategic partnership for RLS to distribute Sofie's radiopharmaceuticals.June 21, 2023UltrasoundPhilips to unveil new ultrasound unit at ASE 2023Philips will showcase its new 5500CV portable ultrasound system at the upcoming 2023 American Society of Echocardiography (ASE) meeting in National Harbor, MD.June 21, 2023Previous PagePage 22 of 3774Next PageTop StoriesCTCT may best conventional measurements for assessing BMD in diabeticsCT may offer a better picture of fracture risk than conventional bone mineral density (BMD) measurements in people with diabetes.Womens ImagingMRI-based model predicts treatment response in breast cancer patientsAIData transparency is lacking for FDA-cleared Alzheimer's AI technologyWomens ImagingAI spots breast lesions on targeted ultrasoundSponsor ContentWhen CT meets the power of AI everyone benefits.
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
